OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Basic information about memantine and its treatment of Alzheimer's disease and other clinical applications
Bin‐Can Tang, Ya‐Ting Wang, Jie Ren
Ibrain (2023) Vol. 9, Iss. 3, pp. 340-348
Open Access | Times Cited: 37
Bin‐Can Tang, Ya‐Ting Wang, Jie Ren
Ibrain (2023) Vol. 9, Iss. 3, pp. 340-348
Open Access | Times Cited: 37
Showing 1-25 of 37 citing articles:
Unraveling the therapeutic efficacy of resveratrol in Alzheimer’s disease: an umbrella review of systematic evidence
Ali Azargoonjahromi, Fatemeh Abutalebian
Nutrition & Metabolism (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 18
Ali Azargoonjahromi, Fatemeh Abutalebian
Nutrition & Metabolism (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 18
Intranasal Drug Delivery by Nanotechnology: Advances in and Challenges for Alzheimer’s Disease Management
Sayali Dighe, Sunil Jog, Munira Momin, et al.
Pharmaceutics (2023) Vol. 16, Iss. 1, pp. 58-58
Open Access | Times Cited: 24
Sayali Dighe, Sunil Jog, Munira Momin, et al.
Pharmaceutics (2023) Vol. 16, Iss. 1, pp. 58-58
Open Access | Times Cited: 24
The neurotransmitter puzzle of Alzheimer's: Dissecting mechanisms and exploring therapeutic horizons
Monika Sharma, Pankaj Pal, Sukesh Kumar Gupta
Brain Research (2024) Vol. 1829, pp. 148797-148797
Closed Access | Times Cited: 14
Monika Sharma, Pankaj Pal, Sukesh Kumar Gupta
Brain Research (2024) Vol. 1829, pp. 148797-148797
Closed Access | Times Cited: 14
Review on anti-alzheimer drug development: approaches, challenges and perspectives
Abdallah E. Abdallah
RSC Advances (2024) Vol. 14, Iss. 16, pp. 11057-11088
Open Access | Times Cited: 14
Abdallah E. Abdallah
RSC Advances (2024) Vol. 14, Iss. 16, pp. 11057-11088
Open Access | Times Cited: 14
Taming neuroinflammation in Alzheimer's disease: The protective role of phytochemicals through the gut−brain axis
Yoonsu Kim, Jinkyu Lim, Jisun Oh
Biomedicine & Pharmacotherapy (2024) Vol. 178, pp. 117277-117277
Closed Access | Times Cited: 13
Yoonsu Kim, Jinkyu Lim, Jisun Oh
Biomedicine & Pharmacotherapy (2024) Vol. 178, pp. 117277-117277
Closed Access | Times Cited: 13
Glutamatergic Neurotransmission in Aging and Neurodegenerative Diseases: A Potential Target to Improve Cognitive Impairment in Aging
Selma Karime Castillo-Vázquez, Lourdes Massieu, Ruth Rincón-Heredia, et al.
Archives of Medical Research (2024) Vol. 55, Iss. 6, pp. 103039-103039
Closed Access | Times Cited: 9
Selma Karime Castillo-Vázquez, Lourdes Massieu, Ruth Rincón-Heredia, et al.
Archives of Medical Research (2024) Vol. 55, Iss. 6, pp. 103039-103039
Closed Access | Times Cited: 9
Can Memantine Treat Autism? Answers from Preclinical and Clinical Studies
Sawsan Aboul‐Fotouh, Sohir M Zohny, Esraa M. Elnahas, et al.
Neuroscience & Biobehavioral Reviews (2025) Vol. 169, pp. 106019-106019
Closed Access | Times Cited: 1
Sawsan Aboul‐Fotouh, Sohir M Zohny, Esraa M. Elnahas, et al.
Neuroscience & Biobehavioral Reviews (2025) Vol. 169, pp. 106019-106019
Closed Access | Times Cited: 1
Tangeretin offers neuroprotection against colchicine-induced memory impairment in Wistar rats by modulating the antioxidant milieu, inflammatory mediators and oxidative stress in the brain tissue
Olalekan Bukunmi Ogunro, Mojisola Esther Karigidi, Gideon Ampoma Gyebi, et al.
BMC Complementary Medicine and Therapies (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Olalekan Bukunmi Ogunro, Mojisola Esther Karigidi, Gideon Ampoma Gyebi, et al.
BMC Complementary Medicine and Therapies (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Alzheimer’s Disease: Exploring the Landscape of Cognitive Decline
Rumiana Tenchov, Janet M. Sasso, Qiongqiong Angela Zhou
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 21, pp. 3800-3827
Open Access | Times Cited: 6
Rumiana Tenchov, Janet M. Sasso, Qiongqiong Angela Zhou
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 21, pp. 3800-3827
Open Access | Times Cited: 6
Non-Drug and Non-Invasive Therapeutic Options in Alzheimer’s Disease
Alina Simona Șovrea, Adina Bianca Boşca, Eleonora Dronca, et al.
Biomedicines (2025) Vol. 13, Iss. 1, pp. 84-84
Open Access
Alina Simona Șovrea, Adina Bianca Boşca, Eleonora Dronca, et al.
Biomedicines (2025) Vol. 13, Iss. 1, pp. 84-84
Open Access
Unraveling the Therapeutic Potential of Alzheimer’s Drugs: A Comprehensive Review
Anjali Rani, Javed Khan, Lakshika Choudhary, et al.
Tetrahedron (2025), pp. 134517-134517
Closed Access
Anjali Rani, Javed Khan, Lakshika Choudhary, et al.
Tetrahedron (2025), pp. 134517-134517
Closed Access
Future Perspectives of NMDAR in CNS Disorders
Toni Capó, Joan Biel Rebassa, Iu Raïch, et al.
Molecules (2025) Vol. 30, Iss. 4, pp. 877-877
Open Access
Toni Capó, Joan Biel Rebassa, Iu Raïch, et al.
Molecules (2025) Vol. 30, Iss. 4, pp. 877-877
Open Access
Exploring Alzheimer's Disease Treatment: Established Therapies and Novel Strategies for Future Care
Urvashi Soni, Kuldeep Singh, Divya Jain, et al.
European Journal of Pharmacology (2025), pp. 177520-177520
Closed Access
Urvashi Soni, Kuldeep Singh, Divya Jain, et al.
European Journal of Pharmacology (2025), pp. 177520-177520
Closed Access
Improving executive functioning and reducing the risk of Alzheimer's disease with music therapy: A narrative review of potential neural mechanisms
Benjamin Slade, Benedict J Williams, Romy Engelbrecht, et al.
Journal of Alzheimer s Disease (2025)
Closed Access
Benjamin Slade, Benedict J Williams, Romy Engelbrecht, et al.
Journal of Alzheimer s Disease (2025)
Closed Access
QSPR Analysis of Some Alzheimer’s Compounds via Topological Indices and Regression Models
Muhammad Shoaib Sardar, Khalil Hadi Hakami
Journal of Chemistry (2024) Vol. 2024, Iss. 1
Open Access | Times Cited: 4
Muhammad Shoaib Sardar, Khalil Hadi Hakami
Journal of Chemistry (2024) Vol. 2024, Iss. 1
Open Access | Times Cited: 4
Recent Advances in Therapeutics for the Treatment of Alzheimer’s Disease
Amin Mahmood Thawabteh, Aseel Wasel Ghanem, Sara AbuMadi, et al.
Molecules (2024) Vol. 29, Iss. 21, pp. 5131-5131
Open Access | Times Cited: 4
Amin Mahmood Thawabteh, Aseel Wasel Ghanem, Sara AbuMadi, et al.
Molecules (2024) Vol. 29, Iss. 21, pp. 5131-5131
Open Access | Times Cited: 4
Analysis of skeletal diversity of multi-target directed ligands (MTDLs) targeting Alzheimer’s disease
Uzma Azam, Muhammad Moazzam Naseer, Christophe Rochais
European Journal of Medicinal Chemistry (2025) Vol. 286, pp. 117277-117277
Open Access
Uzma Azam, Muhammad Moazzam Naseer, Christophe Rochais
European Journal of Medicinal Chemistry (2025) Vol. 286, pp. 117277-117277
Open Access
Drug repurposing for neurodegenerative diseases
Halak Shukla, D. James B. St. John, Shuvomoy Banerjee, et al.
Progress in molecular biology and translational science (2024), pp. 249-319
Closed Access | Times Cited: 2
Halak Shukla, D. James B. St. John, Shuvomoy Banerjee, et al.
Progress in molecular biology and translational science (2024), pp. 249-319
Closed Access | Times Cited: 2
Saponin components in Polygala tenuifolia as potential candidate drugs for treating dementia
Songzhe Li, Zhitao Hou, Ting Ye, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
Songzhe Li, Zhitao Hou, Ting Ye, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
The Neuroprotective Role of Cyanobacteria with Focus on the Anti-Inflammatory and Antioxidant Potential: Current Status and Perspectives
Flávia Guimarães Rodrigues, Mariana Reis, Leonor Vasconcelos Ferreira, et al.
Molecules (2024) Vol. 29, Iss. 20, pp. 4799-4799
Open Access | Times Cited: 2
Flávia Guimarães Rodrigues, Mariana Reis, Leonor Vasconcelos Ferreira, et al.
Molecules (2024) Vol. 29, Iss. 20, pp. 4799-4799
Open Access | Times Cited: 2
Natural Products and Their Neuroprotective Effects in Degenerative Brain Diseases: A Comprehensive Review
Dong Wook Lim, Jung‐Eun Lee, Chang-Ho Lee, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 11223-11223
Open Access | Times Cited: 2
Dong Wook Lim, Jung‐Eun Lee, Chang-Ho Lee, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 11223-11223
Open Access | Times Cited: 2
Glutamate: Molecular Mechanisms and Signaling Pathway in Alzheimer’s Disease, a Potential Therapeutic Target
Nidhi Puranik, Minseok Song
Molecules (2024) Vol. 29, Iss. 23, pp. 5744-5744
Open Access | Times Cited: 2
Nidhi Puranik, Minseok Song
Molecules (2024) Vol. 29, Iss. 23, pp. 5744-5744
Open Access | Times Cited: 2
Mesoporous Silica Nanoparticles: Types, Synthesis, Role in the Treatment of Alzheimer’s Disease, and Other Applications
Bhagavathi Sundaram Sivamaruthi, Devesh U. Kapoor, Rajiv R. Kukkar, et al.
Pharmaceutics (2023) Vol. 15, Iss. 12, pp. 2666-2666
Open Access | Times Cited: 4
Bhagavathi Sundaram Sivamaruthi, Devesh U. Kapoor, Rajiv R. Kukkar, et al.
Pharmaceutics (2023) Vol. 15, Iss. 12, pp. 2666-2666
Open Access | Times Cited: 4
Interactions of memantine and rivastigmine with graphene oxide nanocarrier and beta-amyloid protein using molecular docking and in-silico methods
Fateme Davoudi, Nasrin Shadjou, Mahdieh Darroudi
Heliyon (2024), pp. e37702-e37702
Open Access | Times Cited: 1
Fateme Davoudi, Nasrin Shadjou, Mahdieh Darroudi
Heliyon (2024), pp. e37702-e37702
Open Access | Times Cited: 1
